CollPlant(CLGN) - 2023 Q3 - Quarterly Report

● Received a $10 million milestone payment in the third quarter from partner, AbbVie Inc., for achieving a major milestone in the second quarter in accordance with the strategic collaboration agreement related to the clinical-phase dermal filler product candidate Exhibit 99.1 CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023 ● Company is preparing to launch large-animal study with a commercial size breast implant by year-end ● Cash and cash equivalents totaled $29 million as of Se ...